Home/Filings/4/0001562180-19-000088
4//SEC Filing

DEMAREE JOHN 4

Accession 0001562180-19-000088

CIK 0001560241other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 5:28 PM ET

Size

5.7 KB

Accession

0001562180-19-000088

Insider Transaction Report

Form 4
Period: 2019-01-02
DEMAREE JOHN
Chief Commercial Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    2019-01-02+60,00060,000 total
    Exercise: $19.56Exp: 2029-01-02Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest as to 25% of the shares on January 02, 2020, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Issuer

G1 Therapeutics, Inc.

CIK 0001560241

Entity typeother

Related Parties

1
  • filerCIK 0001744959

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 5:28 PM ET
Size
5.7 KB